FarmPharma AB that is subsidiary to Double Bond Pharmaceutical Int. AB, has been funded with the amount of SEK 400,000 from Vinnova within the project ”BioProcess Innovation Center” to perform a project in collaboration with GE Healthcare and Testa Center in Uppsala. The total budget of the project is 800 000 SEK and the company will cover the other half of the costs according to the general rules of the grant. The project is expected to start during the summer this year and last for three weeks. The purpose of the project is to test the manufacturing procedure of InterferOX components on a larger scale to facilitate the successful transition to industrial GMP manufacturing of the product.
“It is so crucial for us to get financial support for this project that is expected to be a step forward towards our first GMP batch,” – comments Iulia Karlsson, CEO of FarmPharma. – These funds enable us to start a collaboration with GE Healthcare already this spring and take part of their expert knowledge, which we see as an important milestone in the company”s development. ”
More about Testa Center
More about InterferOX